intravitreous aflibercept

DRUG2 trials

Sponsors

Jaeb Center for Health Research, Bayer Thai Co., Ltd.

Conditions

Diabetic Macular EdemaPolypoidal Choroidal Vasculopathy Aflibercept Polypoidal Choroidal Vasculopathy Indocyanine Green Angiography Polyp Regression

Phase 3

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

CompletedNCT03321513

Jaeb Center for Health ResearchDiabetic Macular Edema

Start: 2017-12-07End: 2021-12-22Updated: 2024-04-25

Phase 4

Timing of Complete Polyp Regression Following Aflibercept Treatments in Polypoidal Choroidal Vasculopathy

Active, not recruitingTCTR20181219003

Bayer Thai Co., Ltd.Polypoidal Choroidal Vasculopathy Aflibercept Polypoidal Choroidal Vasculopathy Indocyanine Green Angiography Polyp Regression

Start: 2016-04-04Updated: 2026-08-03

Related Papers

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema

New England Journal of Medicine2022-07-1472 citations